Scott M. Rocklage, Director, 10% Owner at Aprea Therapeutics, Inc. (APRE), sold 240,328 shares at $33.30 ($8.0M) on 2020-06-16, disclosed to the SEC on 2020-06-18.
Open-market sale of $8.0M APRE by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.30 | 4,807 | $160K | 2.0% |
| 2 | $33.30 | 4,807 | $160K | 2.0% |
| 3 | $33.30 | 115,357 | $3.8M | 48.0% |
| 4 | $33.30 | 115,357 | $3.8M | 48.0% |
| Total | $33.30 avg | 240,328 | $8.0M | 100% |
| Filing → |
| APRE | SELL | 2020-06-15 | $7.0M | — | Filing → |
| APRE | SELL | 2020-05-21 | $9.0M | — | Filing → |
| CRNX | SELL | 2019-06-25 | $5.5M | — | Filing → |